Universe Pharmaceuticals INC

Listed Company
UPCCIK 0001809616NasdaqNon-AcceleratedEmerging GrowthPharmaceutical PreparationsF4CNFY ends Sep 30
Period
FY 2025
Revenue
$17.86B
Net Income
$-3.67B
Total Assets
$69.30B
Equity
$56.13B
Shares Out
563.3K
Op. Cash Flow
$-5.05B

Business

Universe Pharmaceuticals INC is a holding company that operates through its PRC subsidiaries to manufacture, market, sell and distribute traditional Chinese medicine-derived (TCMD) pharmaceutical products. It offers its own portfolio of TCMD products focused on chronic condition treatments and cold and flu remedies, and it distributes third-party biomedical drugs, medical instruments, traditional Chinese medicine pieces and dietary supplements. Key business segments include in-house manufacturing, third-party product distribution and research and development through a dedicated R&D subsidiary. Its products are sold across China through pharmaceutical distributors, hospitals, clinics and drugstore chains, and via retailer and digital channels.

Summary from filing dated 2026-01-29

Financials

Latest annual snapshot (FY2025, period end 2025-09-30). Full statement history unavailable for this entity.

Revenue$17.86B
Net income$-3.67B
Total assets$69.30B
Total liabilities$13.17B
Stockholders' equity$56.13B
Operating cash flow$-5.05B

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro